Michelson Medical Research Foundation, Inc. Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001965304

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHigh Turnover how tags are computed

Q2 2025 · 20 positions · Total reported value $104.23M · Top-10 concentration 78.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 25.0% · 3 new · 0 cut · 3 exited

Active Share (vs S&P 500): 99.6% · vs QQQ: 99.4% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.5% · vs SPY -4.7% · Prev Value $108.22M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +1.6% · vs SPY -0.6% · Latest Value $112.52M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2025 13F filing, Michelson Medical Research Foundation, Inc. disclosed 20 equity positions with a combined reported value of $104.23M. The filing implies a focused portfolio: its ten largest positions account for 78.7% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.

The largest disclosed positions as of Q2 2025 were MTN ($13.51M), GDX ($12.20M), RTO ($10.99M). By sector, the heaviest allocations are Consumer Discretionary 26.9%, Financials 6.1%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+3.6pp), Financials (+3.3pp) and away from Other (-8.1pp).

Versus the prior quarter, Michelson Medical Research Foundation, Inc. opened 3 new positions, trimmed 0 and fully exited 3, a turnover rate of 25.0% of positions. The portfolio's overlap with the prior quarter was 67% of names.

The largest new positions opened in Q2 2025 were DBRG ($6.31M), SAFE ($4.63M).

Of the 3 positions fully exited versus the prior quarter, the largest were IJS ($12.67M), IVV ($8.42M), PLD ($3.14M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • DBRG DigitalBridge Group Inc · $6.31M
  • SAFE SAFEHOLD INC · $4.63M

Fully Exited (vs previous quarter)

  • IJS ISHARES TR · prev qtr: $12.67M
  • IVV ISHARES TR · prev qtr: $8.42M
  • PLD PROLOGIS INC. · prev qtr: $3.14M
  • BUR BURFORD CAPITAL LIMITED · prev qtr: $2.38M
  • XBI SPDR SERIES TRUST · prev qtr: $1.57M
  • NML NEUBERGER ENGY INFRSTR & INC · prev qtr: $962.32K
  • CMP COMPASS MINERALS INTL INC · prev qtr: $557.40K

Insider Transactions (Form 4)

Latest Michelson Medical Research Foundation, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Michelson Medical Research Foundation, Inc. is an SEC-registered 13F filer. As of Q2 2026 it reported 21 US equity positions with a combined value of $108.22M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 21 positions · $108.22M reported value (Q2 2026)
  • Top 10 holdings = 72.1% of reported value
  • Largest position: IVE (ISHARES TR) at 10.9%
  • Average position size: $5.15M

Sector Tilt

  • Consumer Discretionary 20.8%
  • Financials 9.8%
  • Real Estate 4.3%
  • (classified holdings cover 36% of value)

Quarterly Activity

  • Q2 2026: 2 new, 2 exited
  • 19 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Financials 6.1%
Energy 1.3%
Other 61.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 86.00K $13.51M 12.96%
12.96%
Hold
2 234.31K $12.20M 11.70%
11.70%
Hold
3 457.81K $10.99M 10.54%
10.54%
Reduce
4 51.91K $10.14M 9.73%
9.73%
Hold
5 158.16K $9.02M 8.65%
8.65%
Hold
6 127.63K $6.31M 6.06%
6.06%
Hold
7 609.50K $6.31M 6.05%
6.05%
New
8 297.48K $4.63M 4.44%
4.44%
New
9 35.38K $4.52M 4.33%
4.33%
Hold
10 35.09K $4.44M 4.26%
4.26%
Reduce
11 63.51K $3.77M 3.62%
3.62%
Reduce
12 200.00K $3.56M 3.42%
3.42%
Hold
13 11.01K $2.61M 2.50%
2.50%
Hold
14 41.85K $2.53M 2.43%
2.43%
Hold
15 81.30K $2.35M 2.25%
2.25%
Hold
16 27.43K $1.57M 1.51%
1.51%
Hold
17 20.10K $1.51M 1.45%
1.45%
Hold
18 16.75K $1.47M 1.41%
1.41%
Hold
19 20.16K $1.45M 1.39%
1.39%
Hold
20 156.17K $1.34M 1.29%
1.29%
Hold

FAQ

What did Michelson Medical Research Foundation, Inc. buy in 2025-Q2?

In its 2025-Q2 13F filing, Michelson Medical Research Foundation, Inc. reported 20 equity positions worth $104.23M in aggregate; its largest disclosed positions were MTN ($13.51M), GDX ($12.20M), RTO ($10.99M).

How large is Michelson Medical Research Foundation, Inc.'s portfolio?

Michelson Medical Research Foundation, Inc. reported $104.23M of long equity holdings across 20 positions as of 2025-Q2. Top-10 holdings account for 78.7% of reported value.

What is Michelson Medical Research Foundation, Inc.'s investment style?

HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/michelson-medical-research-foundation/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →